靶向治疗携带GLDC基因三倍重复拷贝数变异的精神病患者
研究对象为两名携带GLDC基因三倍重复拷贝数变异(推测导致甘氨酸和D-丝氨酸减少及NMDA受体功能低下)的精神病性障碍患者(母子)。方法为开展两项双盲安慰剂对照临床试验,分别使用甘氨酸和D-环丝氨酸增强NMDA受体功能。结论为两种药物均改善精神病性和情绪症状,提供针对特定基因型的个体化治疗原理验证。
要点
- GLDC三倍重复可能降低甘氨酸和D-丝氨酸可用性,导致NMDA受体功能低下。
- 甘氨酸和D-环丝氨酸分别在这两名患者中改善精神病性和情绪症状。
- 结果支持针对特定基因变异进行个体化治疗的精神病学策略。
核心结论
- 针对GLDC三倍重复携带者的NMDA受体增强治疗可缓解精神病性和情绪症状,提供两个独立的原理验证。
研究设计与样本
- 两项双盲、安慰剂对照临床试验,在两名携带GLDC三倍重复拷贝数变异的精神病性障碍患者(母子)中开展。
- 第一项试验使用甘氨酸,第二项试验使用D-环丝氨酸,均为在精神药物治疗基础上增强NMDA受体功能。
主要发现
- 甘氨酸增强精神药物治疗在安慰剂对照试验中改善精神病性和情绪症状。
- D-环丝氨酸增强精神药物治疗在安慰剂对照试验中改善精神病性和情绪症状。
临床怎么用
- 对携带GLDC三倍重复拷贝数变异的精神病患者,可考虑在精神药物治疗基础上使用甘氨酸或D-环丝氨酸增强NMDA受体功能。
局限性
- 证据仅来自两名患者的原理验证试验,样本量极小,结果需在更大样本中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The increased mutational burden for rare structural genomic variants in schizophrenia and other neurodevelopmental disorders has so far not yielded therapies targeting the biological effects of specific mutations. We identified two carriers (mother and son) of a triplication of the gene encoding glycine decarboxylase, GLDC, presumably resulting in reduced availability of the N-methyl-D-aspartate receptor coagonists glycine and D-serine and N-methyl-D-aspartate receptor hypofunction. Both carriers had a diagnosis of a psychotic disorder. METHODS: We carried out two double-blind, placebo-controlled clinical trials of N-methyl-D-aspartate receptor augmentation of psychotropic drug treatment in these two individuals. Glycine was used in the first clinical trial, and D-cycloserine was used in the second one. RESULTS: Glycine or D-cycloserine augmentation of psychotropic drug treatment each improved psychotic and mood symptoms in placebo-controlled trials. CONCLUSIONS: These results provide two independent proof-of-principle demonstrations of symptom relief by targeting a specific genotype and explicitly link an individual mutation to the pathophysiology of psychosis and treatment response.
引用
- Bodkin JA, Coleman MJ, Godfrey LJ, et al. Targeted Treatment of Individuals With Psychosis Carrying a Copy Number Variant Containing a Genomic Triplication of the Glycine Decarboxylase Gene. Biol Psychiatry. 2019. PMID: 31279534. doi:10.1016/j.biopsych.2019.04.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。